Active centres have been designed on high-area, molecular sieve catalysts which, inter alia, can convert n-alkanes to n-alkanols and n-alkanoic acids, cyclohexane to cyclohexanol, cyclohexanone and adipic acid, and n-hexane to adipic acid all using either oxygen or air as oxidants. A number of one-step processes and solvent-free chemical conversions, of paramount importance in the development of clean technology, are also described with catalysts designed (i) to oxidise p-xylene to terephthalic acid aerobically, (ii) to effect Baeyer–Villiger reactions with oxygen, and (iii) for the conversion of cyclohexanone to ε-caprolactam under mild conditions. The inner surfaces of mesoporous silicas may also be atomically engineered so as to yield high-performance epoxidation of alkenes at TiIV-centred active sites, as well as enantioselective hydrogenations of organic species using constrained chiral catalysts.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: